Two Way Bioequivalence Study Under Fed Conditions
NCT01217801
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Ondansetron (ODFS)
DRUG:
Ondansetron (ODT)
Sponsor
MonoSol Rx